EXC 2075: Printing personalized medicines on demand

Research project within the Cluster of Excellence EXC 2075 “Data-Integrated Simulation Science” funded by the German Research Fondation (DFG) - Project number 390740016


Additive manufacturing technologies like printing have tremendous potential to change the field of personalized medicine. Special groups of patients like infants often cannot swallow standard medication that is produced in a one-size-fits all manner. 3D-printing and inkjet printing enable rapid and accurate dispensing of drug-containing inks, thus enabling tailored production of personalized medicine with individual doses and a non-traditional format. We now propose the production of individualized medicine by inkjet-printing into porous substrates. Distribution of the drug-ink in porous substrate will be modeled and validated with drug deposition experimental data. This project will demonstrate the feasibility of individual drug dispensing on patient-friendly substrate materials and is a part of the ERC Proof of Concept (PoC) PrintMed project (No. 963914).

Project leader

Prof. dr. ir. Majid Hassanizadeh
Prof. Dr.-Ing. Rainer Helmig
Prof. Oliver Röhrle



10/2021 - 12/2021



This image shows Majid Hassanizadeh

Majid Hassanizadeh

Prof. dr. ir.

Senior Professor / SFB 1313 Mercator Fellow

This image shows Hamed Aslannejad

Hamed Aslannejad

Dr. Ir.

Departure in October 2022

To the top of the page